| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carrier Proteins | 18 | 2023 | 2139 | 3.870 |
Why?
|
| E2F1 Transcription Factor | 13 | 2020 | 201 | 3.130 |
Why?
|
| DNA-Binding Proteins | 22 | 2023 | 5067 | 2.920 |
Why?
|
| 14-3-3 Proteins | 5 | 2022 | 143 | 2.130 |
Why?
|
| Nuclear Proteins | 17 | 2023 | 3472 | 2.070 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2021 | 882 | 1.890 |
Why?
|
| Tumor Suppressor Protein p53 | 10 | 2023 | 3671 | 1.360 |
Why?
|
| Cell Cycle Proteins | 10 | 2021 | 2129 | 1.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2022 | 2085 | 1.080 |
Why?
|
| DNA Damage | 12 | 2021 | 1989 | 1.060 |
Why?
|
| Ubiquitination | 5 | 2021 | 577 | 0.940 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 6 | 2021 | 437 | 0.900 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 381 | 0.900 |
Why?
|
| Apoptosis | 11 | 2014 | 7837 | 0.830 |
Why?
|
| DNA Replication | 5 | 2021 | 773 | 0.810 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 2 | 2023 | 514 | 0.800 |
Why?
|
| Checkpoint Kinase 1 | 3 | 2021 | 169 | 0.800 |
Why?
|
| GATA3 Transcription Factor | 1 | 2022 | 145 | 0.800 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 703 | 0.790 |
Why?
|
| Cyclin-Dependent Kinase 2 | 3 | 2020 | 253 | 0.780 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2021 | 87 | 0.750 |
Why?
|
| DNA Repair | 4 | 2021 | 1912 | 0.740 |
Why?
|
| Gene Expression Regulation | 8 | 2013 | 4200 | 0.710 |
Why?
|
| Tumor Suppressor Proteins | 8 | 2019 | 1905 | 0.700 |
Why?
|
| Breast Neoplasms | 8 | 2022 | 16244 | 0.690 |
Why?
|
| Phosphorylation | 15 | 2021 | 4984 | 0.650 |
Why?
|
| Promoter Regions, Genetic | 7 | 2019 | 3262 | 0.650 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 1295 | 0.650 |
Why?
|
| Protein Binding | 11 | 2020 | 3528 | 0.620 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 815 | 0.610 |
Why?
|
| Actins | 1 | 2021 | 617 | 0.600 |
Why?
|
| Estrogen Receptor alpha | 1 | 2022 | 743 | 0.600 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2020 | 272 | 0.560 |
Why?
|
| Epidermal Growth Factor | 1 | 2018 | 445 | 0.550 |
Why?
|
| Down-Regulation | 4 | 2012 | 2106 | 0.550 |
Why?
|
| Ovarian Neoplasms | 3 | 2023 | 4797 | 0.540 |
Why?
|
| HEK293 Cells | 7 | 2015 | 1470 | 0.540 |
Why?
|
| Transcription Factors | 10 | 2021 | 5506 | 0.530 |
Why?
|
| Cell Line, Tumor | 13 | 2022 | 14881 | 0.520 |
Why?
|
| Carcinogenesis | 1 | 2021 | 1037 | 0.490 |
Why?
|
| S Phase | 5 | 2020 | 290 | 0.490 |
Why?
|
| Ubiquitin | 3 | 2012 | 335 | 0.480 |
Why?
|
| rho Guanine Nucleotide Dissociation Inhibitor alpha | 1 | 2014 | 14 | 0.480 |
Why?
|
| Mutation, Missense | 2 | 2017 | 1197 | 0.470 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 1075 | 0.470 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 224 | 0.460 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2014 | 76 | 0.460 |
Why?
|
| Oxidative Stress | 1 | 2020 | 1159 | 0.450 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 3417 | 0.450 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2014 | 180 | 0.440 |
Why?
|
| Transcriptional Activation | 4 | 2011 | 1146 | 0.440 |
Why?
|
| Catalytic Domain | 1 | 2014 | 306 | 0.430 |
Why?
|
| Cell Line | 11 | 2020 | 5433 | 0.430 |
Why?
|
| Cell Cycle | 6 | 2020 | 2150 | 0.410 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 46 | 0.410 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 1381 | 0.400 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 2624 | 0.400 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2021 | 1483 | 0.390 |
Why?
|
| Cell Membrane | 1 | 2015 | 900 | 0.390 |
Why?
|
| CCAAT-Binding Factor | 1 | 2011 | 34 | 0.390 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2021 | 2446 | 0.390 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2010 | 621 | 0.350 |
Why?
|
| Membrane Proteins | 2 | 2011 | 2975 | 0.350 |
Why?
|
| Mice | 20 | 2021 | 36053 | 0.340 |
Why?
|
| Proteasome Endopeptidase Complex | 5 | 2013 | 599 | 0.340 |
Why?
|
| Humans | 40 | 2023 | 272087 | 0.340 |
Why?
|
| G1 Phase | 5 | 2011 | 306 | 0.330 |
Why?
|
| Amino Acid Substitution | 3 | 2017 | 661 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2022 | 9101 | 0.330 |
Why?
|
| Chromatin | 3 | 2021 | 1050 | 0.320 |
Why?
|
| Cadherins | 1 | 2012 | 676 | 0.320 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 541 | 0.310 |
Why?
|
| Receptors, Lysophosphatidic Acid | 2 | 2007 | 89 | 0.310 |
Why?
|
| DNA Helicases | 2 | 2023 | 451 | 0.300 |
Why?
|
| Animals | 22 | 2023 | 62822 | 0.300 |
Why?
|
| Cell Proliferation | 2 | 2018 | 7302 | 0.300 |
Why?
|
| Signal Transduction | 5 | 2021 | 12223 | 0.290 |
Why?
|
| Amino Acid Motifs | 2 | 2020 | 416 | 0.280 |
Why?
|
| RNA, Small Interfering | 7 | 2012 | 2219 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 5421 | 0.280 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 5 | 2021 | 86 | 0.260 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2019 | 273 | 0.260 |
Why?
|
| Lysophospholipids | 4 | 2007 | 150 | 0.250 |
Why?
|
| Protein Isoforms | 2 | 2022 | 860 | 0.250 |
Why?
|
| Heterografts | 2 | 2019 | 745 | 0.250 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 5603 | 0.240 |
Why?
|
| Base Pair Mismatch | 1 | 2004 | 82 | 0.240 |
Why?
|
| Autophagy | 1 | 2010 | 922 | 0.230 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 5330 | 0.230 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2023 | 32 | 0.220 |
Why?
|
| Tamoxifen | 2 | 2022 | 906 | 0.220 |
Why?
|
| E2F Transcription Factors | 4 | 2004 | 138 | 0.220 |
Why?
|
| Proteins | 5 | 1996 | 2058 | 0.220 |
Why?
|
| DNA Repair Enzymes | 1 | 2004 | 236 | 0.210 |
Why?
|
| Molecular Docking Simulation | 1 | 2023 | 162 | 0.210 |
Why?
|
| Protein Kinases | 3 | 2021 | 919 | 0.210 |
Why?
|
| Endonucleases | 1 | 2023 | 184 | 0.210 |
Why?
|
| Gene Expression | 2 | 2021 | 3690 | 0.200 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 428 | 0.200 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2021 | 16 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2014 | 3651 | 0.190 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 3 | 1995 | 47 | 0.190 |
Why?
|
| Antigens, CD | 2 | 2012 | 1436 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 1599 | 0.180 |
Why?
|
| Female | 11 | 2023 | 149288 | 0.180 |
Why?
|
| Doxorubicin | 5 | 2008 | 3132 | 0.180 |
Why?
|
| ErbB Receptors | 2 | 2019 | 2383 | 0.180 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 50 | 0.180 |
Why?
|
| Tumor Protein p73 | 2 | 2011 | 114 | 0.180 |
Why?
|
| E2F3 Transcription Factor | 3 | 2004 | 23 | 0.180 |
Why?
|
| Carcinogens | 1 | 2021 | 398 | 0.180 |
Why?
|
| DNA Adducts | 1 | 2021 | 214 | 0.170 |
Why?
|
| Protein Subunits | 2 | 2012 | 282 | 0.170 |
Why?
|
| Cisplatin | 3 | 2021 | 2497 | 0.170 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 1566 | 0.170 |
Why?
|
| Sumoylation | 1 | 2020 | 81 | 0.170 |
Why?
|
| G2 Phase | 1 | 2020 | 218 | 0.170 |
Why?
|
| NIH 3T3 Cells | 4 | 2007 | 259 | 0.170 |
Why?
|
| Genes, p53 | 1 | 2023 | 1146 | 0.160 |
Why?
|
| Cysteine Endopeptidases | 1 | 2020 | 265 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2011 | 5788 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 2472 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1999 | 172 | 0.160 |
Why?
|
| Herpesvirus 6, Human | 1 | 1999 | 81 | 0.160 |
Why?
|
| Thymus Gland | 3 | 2001 | 312 | 0.160 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 1995 | 32 | 0.160 |
Why?
|
| Cyclins | 1 | 2020 | 470 | 0.160 |
Why?
|
| Genomic Instability | 1 | 2021 | 523 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2009 | 1668 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 1501 | 0.150 |
Why?
|
| LIM Domain Proteins | 4 | 2013 | 104 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 12012 | 0.150 |
Why?
|
| Heart Neoplasms | 1 | 2000 | 216 | 0.150 |
Why?
|
| Herpesviridae Infections | 1 | 1999 | 181 | 0.150 |
Why?
|
| Trans-Activators | 1 | 2004 | 1660 | 0.150 |
Why?
|
| Protein Transport | 1 | 2019 | 739 | 0.150 |
Why?
|
| RNA Interference | 2 | 2012 | 1397 | 0.150 |
Why?
|
| Mice, Nude | 3 | 2014 | 4360 | 0.140 |
Why?
|
| Biological Transport | 1 | 2018 | 645 | 0.140 |
Why?
|
| Receptors, Antigen | 2 | 1996 | 68 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1085 | 0.140 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2021 | 621 | 0.140 |
Why?
|
| Transfection | 5 | 2008 | 3166 | 0.130 |
Why?
|
| Lymphoma, T-Cell | 1 | 1999 | 369 | 0.130 |
Why?
|
| Cell Division | 1 | 2020 | 2711 | 0.130 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1995 | 67 | 0.130 |
Why?
|
| Protein Structure, Quaternary | 1 | 2015 | 136 | 0.130 |
Why?
|
| Models, Immunological | 1 | 1995 | 79 | 0.130 |
Why?
|
| DNA, Neoplasm | 1 | 2021 | 1972 | 0.120 |
Why?
|
| Fluoresceins | 1 | 2014 | 74 | 0.120 |
Why?
|
| Survival Analysis | 2 | 2021 | 9326 | 0.120 |
Why?
|
| CDC2 Protein Kinase | 2 | 2011 | 188 | 0.120 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 254 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 5804 | 0.110 |
Why?
|
| Cell Adhesion | 2 | 2014 | 1041 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1435 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 593 | 0.110 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 140 | 0.110 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2000 | 1011 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 1999 | 792 | 0.110 |
Why?
|
| Homeodomain Proteins | 2 | 1995 | 1134 | 0.100 |
Why?
|
| Apc5 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 2 | 0.100 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 554 | 0.100 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 1086 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2013 | 233 | 0.100 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2012 | 28 | 0.100 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2013 | 153 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 2013 | 224 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3363 | 0.100 |
Why?
|
| Cell Movement | 4 | 2013 | 2504 | 0.100 |
Why?
|
| Disease Progression | 2 | 2022 | 6911 | 0.100 |
Why?
|
| Serine | 1 | 2013 | 394 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3929 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 300 | 0.100 |
Why?
|
| Mutation | 6 | 2019 | 15944 | 0.100 |
Why?
|
| Amino Acid Sequence | 4 | 2007 | 4635 | 0.100 |
Why?
|
| Cyclin A | 1 | 2011 | 50 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 1143 | 0.100 |
Why?
|
| DNA Primers | 1 | 2014 | 1513 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2021 | 5841 | 0.100 |
Why?
|
| Neoplasms | 3 | 2014 | 15930 | 0.100 |
Why?
|
| Molecular Sequence Data | 5 | 2007 | 6783 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1999 | 1659 | 0.090 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2011 | 98 | 0.090 |
Why?
|
| B-Lymphocytes | 2 | 1994 | 1429 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 380 | 0.090 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 557 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2014 | 3646 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1212 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2015 | 6489 | 0.090 |
Why?
|
| Beclin-1 | 1 | 2010 | 89 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2013 | 494 | 0.090 |
Why?
|
| Tenascin | 1 | 2010 | 56 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2019 | 2761 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 1993 | 817 | 0.080 |
Why?
|
| Protein Stability | 1 | 2010 | 376 | 0.080 |
Why?
|
| MutL Protein Homolog 1 | 2 | 2010 | 206 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2008 | 544 | 0.080 |
Why?
|
| Rad51 Recombinase | 1 | 2008 | 125 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 181 | 0.070 |
Why?
|
| Camptothecin | 1 | 2010 | 538 | 0.070 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 512 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 194 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2008 | 909 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 193 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 481 | 0.070 |
Why?
|
| Glutathione Transferase | 2 | 2004 | 371 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7476 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 529 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 4071 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5248 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 1093 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 895 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 703 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1547 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2006 | 257 | 0.060 |
Why?
|
| Drug Stability | 1 | 2004 | 108 | 0.060 |
Why?
|
| MutL Proteins | 1 | 2004 | 30 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2006 | 280 | 0.060 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2004 | 49 | 0.060 |
Why?
|
| Cell Survival | 2 | 2010 | 3074 | 0.060 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 14653 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 212 | 0.060 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 342 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2006 | 493 | 0.060 |
Why?
|
| E2F2 Transcription Factor | 1 | 2003 | 27 | 0.060 |
Why?
|
| E2F4 Transcription Factor | 1 | 2003 | 30 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2013 | 1740 | 0.050 |
Why?
|
| DNA | 3 | 2004 | 3089 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 1534 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 1832 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 745 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 1842 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2003 | 487 | 0.040 |
Why?
|
| Machine Learning | 1 | 2023 | 358 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 664 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 1720 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2003 | 522 | 0.040 |
Why?
|
| Pancreas | 1 | 2023 | 746 | 0.040 |
Why?
|
| Glomerulonephritis, IGA | 1 | 1999 | 19 | 0.040 |
Why?
|
| Etoposide | 1 | 2001 | 905 | 0.040 |
Why?
|
| Models, Biological | 1 | 2007 | 3223 | 0.040 |
Why?
|
| CD8 Antigens | 1 | 1999 | 173 | 0.040 |
Why?
|
| VDJ Recombinases | 2 | 1995 | 14 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2004 | 1670 | 0.040 |
Why?
|
| Cladribine | 1 | 1999 | 253 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 908 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 3072 | 0.040 |
Why?
|
| Periodicity | 1 | 1996 | 71 | 0.030 |
Why?
|
| Survival Rate | 1 | 2009 | 12534 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1995 | 138 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 1995 | 60 | 0.030 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 1995 | 112 | 0.030 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 1994 | 38 | 0.030 |
Why?
|
| Zyxin | 1 | 2013 | 5 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 668 | 0.030 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2013 | 94 | 0.030 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2013 | 53 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1993 | 387 | 0.030 |
Why?
|
| Mitosis | 1 | 1995 | 692 | 0.030 |
Why?
|
| Cytosol | 1 | 2013 | 271 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 340 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2005 | 487 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 504 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1999 | 2446 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1999 | 962 | 0.020 |
Why?
|
| Mice, SCID | 1 | 1995 | 1851 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 2 | 1996 | 1373 | 0.020 |
Why?
|
| Metallothionein | 1 | 1990 | 33 | 0.020 |
Why?
|
| Columbidae | 1 | 1990 | 24 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2010 | 233 | 0.020 |
Why?
|
| Ploidies | 1 | 2010 | 257 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1994 | 1396 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2010 | 212 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 1524 | 0.020 |
Why?
|
| DNA Mismatch Repair | 1 | 2010 | 284 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1994 | 3078 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2007 | 79 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 2457 | 0.020 |
Why?
|
| Paxillin | 1 | 2003 | 32 | 0.010 |
Why?
|
| Tyrosine | 1 | 2005 | 510 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 360 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1999 | 5693 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 116 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 163 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 307 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2013 | 1781 | 0.010 |
Why?
|
| Glioma | 1 | 2013 | 1988 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 953 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 782 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 31066 | 0.010 |
Why?
|
| Liver | 1 | 1990 | 3123 | 0.010 |
Why?
|
| Male | 2 | 2000 | 129088 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 1230 | 0.010 |
Why?
|
| Aged | 1 | 2000 | 73517 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1993 | 336 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 735 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1993 | 289 | 0.010 |
Why?
|
| Middle Aged | 1 | 1999 | 90460 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1990 | 262 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1990 | 422 | 0.010 |
Why?
|
| Zinc | 1 | 1990 | 194 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1990 | 233 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1990 | 591 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 5502 | 0.000 |
Why?
|
| Amino Acids | 1 | 1990 | 788 | 0.000 |
Why?
|